Design and evaluation of bilayer floating tablets of cefuroxime axetil for bimodal release

Journal of Scientific and Industrial Research

Volumn 65, Issue 10, 2006, Pages 812-816

  Dhumal, Ravindra S ^a   Rajmane, Samitkumar T ^a   Dhumal, Sanjay T ^b   Pawar, Atmaram P ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b LUPIN LIMITED   (India)

Author keywords

Bimodal drug delivery; Cefuroxime axetil; Floating drug delivery system; Gastroretention

Indexed keywords

ABSORPTION; ANTIBIOTICS; BIOLOGICAL MATERIALS; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; GASTROENTEROLOGY; HYDROLYSIS; PHARMACODYNAMICS;

ABSORPTION; DRUG; HYDROLYSIS;

EID: 33750096128     PISSN: 00224456     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Porter S C & Ghebre-Sellassie I, Key factors in the development of modified-release pellets, in Multiparticulate Oral Drug Delivery: Ghebre-Sellassie, 1st edn (Marcel Dekker, New York) 1994, 217-284.
2. Singh B N & Kim K H, Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention, J Control Rel, 63 (2000) 235-259.
3. Klokkers-Bethke K & Fisher W, Development of a multiple unit drug delivery system for positioned release in the gastrointestinal tract, J Contro Rel, 15 (1991) 105-112.
4. Sharma S, & Pawar A, Low-density porous multiparticulate system for pulsatile release of meloxicam, Int J Pharm (in press).
5. Badve S, Sher P, Korde A & Pawar A, Development of hollow/porous calcium pectinate beads for floating pulsatile drug delivery, Eur J Pharm Biopharm (in press).
6. Somani J K, Bhushan I & Sen H, Process for preparation of a bioavailable dosage form of Cefuroxime axetil, U S Pat 6,346,530, 12 Feb 2002.
7. Somani J K, Bhushan I & Sen H, Bioavailable dosage form of cefuroxime axetil, U S Pat 6,323,193, 27 Nov 2001.
8. Handa V K, Dandala V R & Khanna J M, Process for preparation of cefuroxime, U S Pat 6,235,896, 22 May 2001.
9. Handa V K, Tyagi O D & Ray U K, Process for preparing a pure, Pharmacopocial grade of cefuroxime axetil, U S Pat 6,384,213, 7 May 2002.
10. Somani J K, Sethi S & Tyagi O D, Process for preparation of cefuroxime axetil in amorphous form, U S Pat 6,060,599, 9 May 2000.
11. Physician desk reference, Lederle Pharmaceutical, (2001) 1898-1902.
12. Adams D H, Wood M J, Farrell I D, Fox C & Ball A P. Oral cefuroxime axetil: clinical pharmacological and comparative dose studies in urinary tract infection, J Antimicrob Chemother, 16 (1985) 359-366.
13. Akhilo K & Teruo O, Pulsatile drug release control using hydrogels, Adv Drug Deliv Rev, 54 (2002) 53-77.
14. Rinat M I, Akhilo K & Teruo O, Time programmed pulsatile release of dextran from calcium alginate beads coated with carboxy-n-propylacrylamide copolymers, J Control Rel, 80 (2002) 57-68.
15. Lin S Y, Lin K H & Li M J, Formulation design of double-layer in the outer shell of dry coated tablet to modulate lag time and time controlled dissolution function: studies on micronized ethylcellulose for dosage form design (VII), AAPS J, 6 (2004) Article 17.
16. Lin S Y, Lin K H & Li M J, Micronized ethylcellulose used for designing a directly compressed time-controlled disintegration tablet. J Control Rel, 70 (2001) 321-328.
17. Fan T Y, Wei S L, Yan W W, Chen D B & Li J, An investigation of pulsatile release tablets with ethylcellulose and eudrajit L as coating materials and cross linked polyvinylpyrrlidone in the core tablets, J Control Rel, 77 (2001) 245-251.
18. Krogel I & Bodmeier J, Floating or pulsatile drug delivery system based on coated effervescent cores, Int J Pharm, 187 (1999) 175-184.
19. Guoje X & Sunada H, Influence of formulation change on drug release kinetics from hydroxypropylmethyl-cellulose matrix tablets, Chem Pharm Bull, 43 (1995) 483-487.
20. Shimpi S, Chauhan B, Mahadik K R & Paradkar A R, Preparation and evaluation of diltiazem hydrochloride-Gelucier 43/01 floating granules prepared by melt granulation, AAPS Pharm Sci Tech, 5 (2004) Article 43.
21. Wilson C G, Washington N, Norman S, Greaves J L, Peach J M & Pugh K A, Gamma scintigraphic study to compare oesophageal clearance of 'Expidet' formulations, tablets and capsules in supine volunteers, Int J Pharm, 46 (1988) 241-246.